Endocrine & hormone · target hub
Relaxin-3 receptor 1 (RXFP3)
RXFP3 is a Membrane hormone receptor (RTK/GPCR) on the endocrine & hormone axis. Receptor for RNL3/relaxin-3. Binding of the ligand inhibit cAMP accumulation It is indexed under "Glycoprotein-hormone receptors & related GPCRs" on our pathway page for antibodies, inhibitors, and assay guidance.
| Type / example | Domain / context (brief) |
|---|---|
| Ligand stimulation | Ligand-dependent phosphorylation |
| GPCR desensitization | β-arrestin / internalization control |
| CN / expression | Copy number & tissue expression |
Naming and prevalence vary by cohort and assay—annotate clinically with COSMIC, ClinVar, OncoKB, and datasheets; research context only.
Examples below reflect common literature and public resources (e.g., CCLE, DepMap)—validate genotypes, expression, and passage in your own stocks before committing assays.
Human tissues and primary cells require ethics/IRB approval; tumors are heterogeneous—record histotype, site, and preservation conditions.
Overexpression vs endogenous RXFP3 can differ in dosage, splicing, and compartmentation—in organoids/PDX, record passage, matrix, and drug history.
Adds RXFP3 keyword bias atop the 内分泌和激素 antibody pool—if sparse, use presets above or global search.
This content supports research reagents and pathway education—not medical advice. Annotate mutations, drug indications, and protocols with authoritative databases, datasheets, and institutional oversight.
Last reviewed: 2026-05-18
See the endocrine & hormone hub for neighboring targets—cross-check PI3K, MAPK, RTK, and metabolism pages as needed.